Treatment With Eribulin Mesylate in Metastatic Breast Cancer
Автор: OncLive
Загружено: 2013-08-07
Просмотров: 2310
Описание:
In this segment, panelists explore the cytotoxic agent eribulin mesylate, which has been the focus of several recent clinical trials. In all, despite a growing focus on targeted therapies, cytotoxics remain an important class of drugs in the treatment of patients with metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: